Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1053 of 5804
-
New drug cocktail aims to stop bile duct cancer from coming back
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether adebrelimab combined with S-1 works as an adjuvant treatment for patients with cholangiocarcinoma after curative surgery. It will also learn about the safety of this treatment. The main questions it aims to answer are: * Does a…
Phase: PHASE2 • Sponsor: Xingjun Guo • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New weekly shot could help shed pounds in obesity trial
Disease control Recruiting nowThe purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treat…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New vaccine combo aims to rally immune system against tough cancers
Disease control Recruiting nowThis is an open-label, non-randomized, single-center, dose-escalation Phase 1 trial using a heterologous prime-boost strategy of vaccination with Ad5.F35-hGUCY2C-PADRE and recombinant Listeria monocytogenes (Lm-GUCY2C) vaccines in patients with advanced solid tumors including col…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Experimental cocktail aims to outsmart tough lung cancer
Disease control Recruiting nowThe primary objective of this trial is to evaluate the safety and tolerability of tarlatamab in combination with ZL-1310 with or without durvalumab and to determine the maximum tolerated combination dose (MTCD) and/or recommended phase 2 dose (RP2D) of ZL-1310 in combination with…
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
AI could spot pancreatic cysts more accurately than doctors
Diagnosis Not yet recruitingThe aim of this study is to develop and validate an artificial intelligence system named iEUS-PCL (intelligent endoscopic ultrasound system-pancreatic cystic lesions) for detecting and multimodal, multi-class diagnosing pancreatic cystic lesions (PCL) during endoscopic ultrasound…
Sponsor: Qilu Hospital of Shandong University • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
New injection aims to restore hearing in sudden deafness
Disease control Not yet recruitingSafety and efficacy of intracochlear injection of glucocorticoid through the round window membrane in patients with profound or complete sudden sensorineural hearing loss
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New hope for aggressive lymphoma: triple-drug combo enters first human tests
Disease control Not yet recruitingA Single-Arm, Prospective Clinical Study Evaluating the Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined with Obinutuzumab in the First-Line Treatment of Newly Diagnosed Intermediate-to-High-Risk Mantle Cell Lymphoma
Phase: PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood test could catch hip disease before It's too late
Diagnosis Recruiting nowOsteonecrosis of the femoral head (ONFH) presents a rapidly progressive natural disease course. Femoral head collapse may occur within two years, ultimately necessitating total hip arthroplasty and imposing a heavy medical and economic burden on patients. Early intervention can s…
Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New laser microscope could help surgeons save nerves during prostate cancer surgery
Diagnosis Recruiting nowThe goal of this study is to find out whether a new method called "LaserSAFE" can accurately detect cancer at the edge of the prostate (called a positive margin) during prostate surgery. LaserSAFE uses a special microscope in the operating room to quickly scan the prostate after …
Phase: NA • Sponsor: University College, London • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
New hope for kids with arthritis: Long-Term drug study launches
Disease control Recruiting nowThis OLE study is designed to evaluate long-term safety, tolerability, and efficacy of filgotinib in patients with polyarticular or systemic juvenile idiopathic arthritis (pJIA-sJIA) who have completed the treatment period/prolonged treatment period of the parent studies and demo…
Phase: PHASE3 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Brain cancer patients get continued access to promising combo therapy in long-term safety study
Disease control Recruiting nowThis clinical trial is a rollover study designed to provide continued access to NBM-BMX and temozolomide (TMZ) for eligible participants with newly diagnosed glioblastoma who have completed the designated treatment in Study NBM-BMX-003 (the parent study), and to evaluate the long…
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for DMD: Long-Term trial of weekly infusions begins
Disease control ENROLLING_BY_INVITATIONThis open-label extension study aims to evaluate the long-term safety and tolerability of weekly BMN 351 infusions, as well as to assess the effect of BMN 351 on physical function, in participants with DMD who participated in the 351-201 study.
Phase: PHASE2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Simple blood test could spot osteoarthritis years earlier
Diagnosis Recruiting nowOsteoarthritis (OA) is the most prevalent degenerative joint disease worldwide, which causes pain, loss of joint function and declined quality of life, and ranks as the leading cause of disability among individuals aged over 60 years. In China, the number of patients with osteoar…
Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Heart stent patients: could a tailored blood thinner dose prevent clots and bleeding?
Disease control Recruiting nowPatients who undergo percutaneous coronary intervention (PCI) are commonly treated with antiplatelet therapy to prevent stent thrombosis and recurrence of events. After an initial period of dual antiplatelet therapy, long-term treatment with a single P2Y12 inhibitor (such as clop…
Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Promising combo aims to shrink tumors in elderly breast cancer patients
Disease control Not yet recruitingEnglish Translation (Professional Medical Version) This study is a multicenter, prospective clinical trial designed to investigate the efficacy and safety of neoadjuvant therapy with trastuzumab plus pertuzumab combined with metronomic vinorelbine chemotherapy in elderly patients…
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug aims to unblock Crohn's-Damaged intestines
Disease control Recruiting nowThis is an open-label, single-arm, phase 4 study to assess the safety and efficacy of mirikizumab in approximately 60 participants with stricturing CD.
Phase: PHASE4 • Sponsor: Alimentiv Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could your own belly fat fix a stubborn Crohn's fistula?
Disease control Recruiting nowPerianal fistulizing Crohn's disease (pCD) represents a severe phenotype of Crohn's disease, affecting approximately 20-30% of patients and resulting in chronic drainage, recurrent sepsis, impaired continence, and reduced quality of life. Despite optimization of biologics, antibi…
Phase: NA • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New lupus pill enters Mid-Stage trial – hope for better control?
Disease control Recruiting nowThis study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps people with SLE. The study tests different doses of BI 3000202 and aims to find the best dose for people with this condition. …
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowA Phase II study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of IBI343 in combination therapy for patients with advanced malignant solid tumors.To evaluate the efficacy and safety of IBI343 in combination therapy for patients with advanced malignant solid…
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
One shot to ease anxiety? new drug RE104 enters human trial
Symptom relief Recruiting nowThe purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.
Phase: PHASE2 • Sponsor: Reunion Neuroscience Inc • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC